- Home
- BRTX vs PSTV Comparison
BRTX vs PSTV Comparison
Compare BRTX & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- PSTV
- Stock Information
- Founded
- BRTX 1997
- PSTV 1996
- Country
- BRTX United States
- PSTV United States
- Employees
- BRTX N/A
- PSTV N/A
- Industry
- BRTX Managed Health Care
- PSTV Medical/Dental Instruments
- Sector
- BRTX Health Care
- PSTV Health Care
- Exchange
- BRTX Nasdaq
- PSTV Nasdaq
- Market Cap
- BRTX 12.6M
- PSTV 10.4M
- IPO Year
- BRTX N/A
- PSTV N/A
- Fundamental
- Price
- BRTX $1.61
- PSTV $0.32
- Analyst Decision
- BRTX Strong Buy
- PSTV Strong Buy
- Analyst Count
- BRTX 1
- PSTV 3
- Target Price
- BRTX $18.00
- PSTV $10.83
- AVG Volume (30 Days)
- BRTX 253.7K
- PSTV 67.2M
- Earning Date
- BRTX 08-12-2025
- PSTV 08-13-2025
- Dividend Yield
- BRTX N/A
- PSTV N/A
- EPS Growth
- BRTX N/A
- PSTV N/A
- EPS
- BRTX N/A
- PSTV N/A
- Revenue
- BRTX $391,000.00
- PSTV $5,206,000.00
- Revenue This Year
- BRTX $391.52
- PSTV $13.26
- Revenue Next Year
- BRTX $3.50
- PSTV $8.84
- P/E Ratio
- BRTX N/A
- PSTV N/A
- Revenue Growth
- BRTX 161.54
- PSTV N/A
- 52 Week Low
- BRTX $1.21
- PSTV $0.16
- 52 Week High
- BRTX $2.55
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- BRTX 46.78
- PSTV 47.17
- Support Level
- BRTX $1.57
- PSTV $0.17
- Resistance Level
- BRTX $1.72
- PSTV $0.44
- Average True Range (ATR)
- BRTX 0.13
- PSTV 0.05
- MACD
- BRTX -0.01
- PSTV 0.02
- Stochastic Oscillator
- BRTX 20.65
- PSTV 55.39
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).